Summary — S.1753 (Massachusetts) — "An Act strengthening synthetic drug laws in correctional facilities"
Status snapshot
- Introduced (Senate Docket No. 2388) — filed 1/17/2025; presented by Sen. Patrick M. O’Connor with multiple co-petitioners.
- Bill text amends Chapter 94C (controlled substances) of the Massachusetts General Laws.
- Committee activity in the provided record includes referrals and a hearing (hearing scheduled 06/26/2025; committee reported favorably 07/21/2025 and referred to Senate Ways & Means). The metadata supplied to this request contains some inconsistent committee/sponsor entries (see “Notes on source inconsistencies” below).
Purpose and intent
- The bill seeks to strengthen criminal penalties for possession, distribution, or use of certain synthetic or “mind‑altering” chemical substances when those acts occur in correctional facilities. The intent is to deter smuggling and use of synthetic drugs inside prisons and jails and to increase public safety for incarcerated people and staff.
Key provisions
- Amends Section 32B of Chapter 94C by adding a sentence that:
- Prohibits any Class C substance (as defined in section 31), any synthetic chemical substance, or any agent that has mind‑altering or mood‑changing effects from being in correctional facilities.
- Declares distribution, possession, or use of such substances in correctional facilities to be a felony.
- Prescribes a mandatory minimum jail or prison sentence of 2.5 years “on or after their current prison sentence” (text as drafted; phrase is ambiguous and appears to impose at least a 2.5‑year sentence).
Who would be affected
- Incarcerated individuals found in possession, distribution, or use of the specified substances inside correctional facilities.
- Visitors, vendors, contractors, staff, and anyone who brings such substances into a correctional setting.
- Corrections agencies, prosecutors, public defenders, and courts (increased investigations, prosecutions, and sentencing decisions).
- Potentially the state corrections budget and population due to mandatory minimum sentences.
Potential impacts and considerations
- Public safety: May reduce in‑facility drug use and related harms (overdoses, violence), if enforcement is effective.
- Criminal justice: Establishes felony status with a mandatory minimum sentence, which could increase incarceration time and workload for courts/prosecutors.
- Operational: Could require enhanced screening/searches, staff training, and evidence-handling protocols in correctional facilities.
- Legal issues: Ambiguities in the draft (e.g., “on or after their current prison sentence”) and broad wording (“mind altering or mood changing effects”) may prompt challenges on vagueness, proportionality, or sentencing grounds.
- Public health: Criminalization-focused approach may limit use of treatment‑oriented responses inside correctional facilities.
Procedural/timeline notes
- Filed Jan 17, 2025. Hearing scheduled for 06/26/2025 per the record; reported favorably by committee 07/21/2025 and referred to Senate Ways & Means. Final legislative status should be checked with the official state legislative website for updates.
Notes on source inconsistencies
- The provided materials include conflicting metadata (references to “Bella’s Law”/animal abuse, federal sponsors, multiple committees). This summary is based on the bill text and docket (Massachusetts Senate No. 1753) which addresses synthetic chemical substances in correctional facilities. If you intended a different bill (e.g., Bella’s Law), please provide the correct text/docket for a targeted summary.